Intervention not reported
Pain intensity Various validated pain scales · Patients with osteoarthritis of the knee
The intervention showed no clear difference in pain intensity Various validated pain scales (low certainty).
1 finding from 1 review
Adverse effects ‐ cardiovascular ‐ hypotension · patients with psychosis‐induced aggression or agitation
It is very uncertain whether CHLORPROMAZINE changes adverse effects ‐ cardiovascular ‐ hypotension compared with HALOPERIDOL (very low certainty).
1 finding from 1 review
Pain intensity various scales short‐term · Patients with acute low‐back pain
1 finding from 1 review
Pain intensity, long‐term · Patients with acute low‐back pain
1 finding from 1 review
Pain intensity various scales short‐term · patients with sciatica
1 finding from 1 review
Pain intensity, long‐term · patients with sciatica
1 finding from 1 review
Pain intensity (0‐10cm visual analogue scale) · rotator cuff disease
1 finding from 1 review
Intervention not reported
Muscle strength Isometric extension · patients with patients with Rheumatoid Arthritis
1 finding from 1 review
Intervention not reported
Muscle strength Isometric extension · patients with Rheumatoid Arthritis
1 finding from 1 review
Intervention not reported
Muscle strength Isometric extension · patients with Rheumatoid Arthritis
1 finding from 1 review
Admission to neonatal intensive care unit · pregnant women to prevent adverse pregnancy outcome
AFI showed no clear difference in admission to neonatal intensive care unit compared with SDVP: summary of findings table (moderate certainty).
1 finding from 1 review
Change in isokinetic knee extension torque (Nm) · patients with people with peripheral neuropathy
1 finding from 1 review
All‐cause mortality · adults with primary (essential) hypertension whose systolic or diastolic (or both) blood pressure levels were 130/80 mmHg or greater
It is very uncertain whether evening changes all‐cause mortality compared with morning dosing regimen (very low certainty).
1 finding from 1 review
Cardiovascular mortality · adults with primary (essential) hypertension whose systolic or diastolic (or both) blood pressure levels were 130/80 mmHg or greater
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiovascular morbidity · adults with primary (essential) hypertension whose systolic or diastolic (or both) blood pressure levels were 130/80 mmHg or greater
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · adults with primary (essential) hypertension whose systolic or diastolic (or both) blood pressure levels were 130/80 mmHg or greater
It is very uncertain whether evening changes serious adverse events compared with morning dosing regimen (very low certainty).
1 finding from 1 review
Overall adverse events · adults with primary (essential) hypertension whose systolic or diastolic (or both) blood pressure levels were 130/80 mmHg or greater
It is very uncertain whether evening changes overall adverse events compared with morning dosing regimen (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults with primary (essential) hypertension whose systolic or diastolic (or both) blood pressure levels were 130/80 mmHg or greater
It is very uncertain whether evening changes withdrawals from treatment due to adverse events compared with morning dosing regimen (very low certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality at 31 to 100 days · Adults with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem…
It is very uncertain whether the intervention changes all‐cause mortality at 31 to 100 days (very low certainty).
1 finding from 1 review
Intervention not reported
Number of participants with any bleeding ‐ not reported · Adults with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found